LIFECORE BIOMEDICAL, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
LIFECORE BIOMEDICAL, INC. (LFCR) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $215.00 thousand as of 2022-05-29, per its 10-K/A filed 2023-03-16.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2023-03-16
- 2022-05-29: Finite-Lived Intangible Asset, Expected Amortization, Year One $215.00K; Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed $1.10M.
- 2021-05-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.96M.
- 2020-05-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.80M.
- 2019-05-26: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.90M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One | Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed |
|---|---|---|
| 2022-05-29 | $215.00K 10-K/A · filed 2023-03-16 | $1.10M 10-K · filed 2022-09-14 |
| 2021-05-30 | $1.96M 10-K · filed 2021-07-29 | |
| 2020-05-31 | $1.80M 10-K · filed 2020-08-14 | |
| 2019-05-26 | $1.90M 10-K · filed 2019-08-01 | |
| 2018-05-27 | $949.00K 10-K · filed 2018-08-09 | |
| 2017-05-28 | $949.00K 10-K/A · filed 2018-03-15 | |
| 2016-05-29 | $885.00K 10-K · filed 2016-08-01 | |
| 2014-05-25 | $885.00K 10-K · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |